India’s antitrust regulator has asked drug maker Sun Pharmaceutical Industries Ltd. to rework its $3.2 billion proposed merger with Ranbaxy Laboratories Ltd.
from WSJ.com: US Business http://ift.tt/1zTOjOU
via IFTTT
from WSJ.com: US Business http://ift.tt/1zTOjOU
via IFTTT
No comments:
Post a Comment